Serum Institue of India’s Poonawalla expects Omicron-specific vaccine in 6 months: Report

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.

By: Reuters |
August 15, 2022 11:14:51 pm
Serum Institute of India's Chief Executive Officer Adar Poonawalla

Serum Institute of India’s (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest India News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
First published on: 15-08-2022 at 11:14:51 pm
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Live Blog
    Best of Express
    Advertisement
    Must Read
    Advertisement
    Buzzing Now
    Advertisement